Trials / Not Yet Recruiting
Not Yet RecruitingNCT07142941
Exercise and/or HMB in Older Diabetes With Low Muscle Mass
Effects of Exercise and/or β-hydroxy-β-methylbutyrate Supplementation on Muscle Mass, Physical Performance and Insulin Resistance in Older Diabetes With Low Muscle Mass: a Randomized, Double-blind, Placebo-controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Wu Shangling · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aimed to examine if β-hydroxy-β-methylbutyrate (HMB) supplementation enhances the effects of exercise on muscle mass, physical performance and insulin resistance and observe potential residual effects in older diabetes with low muscle mass, and to find the optimal treatment plan.
Detailed description
The interaction between exercise and nutritional supplementation is unclear among older diabetes at risk of sarcopenia. The investigators aimed to examine if β-hydroxy-β-methylbutyrate (HMB) supplementation enhances the effects of exercise on muscle mass, physical performance and insulin resistance and observe potential residual effects in older diabetes with low muscle mass, and to find the optimal treatment plan. This 12-wk, randomized, double-blind, placebo controlled, 2 × 2 factorial design (exercise-only, HMB-only, both, and none) trial included 120 older diabetes aged 60-80 y with skeletal muscle index \<5.7 kg/m2 for women, and \<7.0 kg/m2 for men, and was followed by a 12-wk observational period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | HMB | Participants were instructed to take active products including 3000 mg calcium-HMB per day |
| BEHAVIORAL | Exercise | Participants allocated to the exercise programs were provided 45 min of supervised sessions on 2 nonconsecutive days per week |
| DIETARY_SUPPLEMENT | Placebo | Participants were instructed to take active products including equal in quality resistant dextrin per day |
| OTHER | Education | Participants were given health education and educational manuals |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2025-08-27
- Last updated
- 2026-03-31
Source: ClinicalTrials.gov record NCT07142941. Inclusion in this directory is not an endorsement.